These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 10072122)

  • 1. A case of primary refractory Hodgkin's disease treated successfully with paclitaxel.
    Kallab AM; Dainer P
    Am J Hematol; 1999 Mar; 60(3):248. PubMed ID: 10072122
    [No Abstract]   [Full Text] [Related]  

  • 2. Paclitaxel in the salvage treatment of Hodgkin's disease and non-Hodgkin's lymphoma.
    Hopfinger G; Heinz R; Pfeilstöcker M; Schlögl E; Waldner R; Pittermann E
    Ann Oncol; 1996 Apr; 7(4):423-4. PubMed ID: 8805938
    [No Abstract]   [Full Text] [Related]  

  • 3. Treatment of childhood Hodgkin's disease with ABVD without radiotherapy.
    Behrendt H; Brinkhuis M; Van Leeuwen EF
    Med Pediatr Oncol; 1996 Apr; 26(4):244-8. PubMed ID: 8600335
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low-dose weekly paclitaxel for recurrent or refractory aggressive non-Hodgkin lymphoma.
    Rizzieri DA; Sand GJ; McGaughey D; Moore JO; DeCastro C; Chao NJ; Vredenburgh JJ; Gasparetto C; Long GD; Anderson E; Foster T; Toaso B; Adams D; Niedzwiecki D; Gockerman JP
    Cancer; 2004 Jun; 100(11):2408-14. PubMed ID: 15160345
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hypothermia and Hodgkin's disease: case report and review of the literature.
    Meert AP; Berghmans T; Sculier JP
    Acta Clin Belg; 2006; 61(5):252-4. PubMed ID: 17240740
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hodgkin's disease and hypothermia: case report and review of the literature.
    Robin V; Lebacq J; Michaux L; Ferrant A
    Ann Hematol; 2002 Feb; 81(2):106-7. PubMed ID: 11907792
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phase II study of 3-hour infusion of high dose paclitaxel in refractory and relapsed aggressive non-Hodgkin's lymphomas. Groupe d'Etude des Lymphomes de l'Adulte.
    Casasnovas RO; Haioun C; Dumontet C; Gabarre J; Richard B; Lederlin P; Caillot D; Stamatoullas A; Morel P; Quesnel B; Blay JY; Bouabdallah K; Gisselbrecht C
    Haematologica; 2000 May; 85(5):502-7. PubMed ID: 10800167
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phase II study of weekly low-dose paclitaxel for relapsed and refractory non-Hodgkin's lymphoma: a Wisconsin Oncology Network Study.
    Kahl BS; Bailey HH; Smith EP; Turman N; Smith J; Werndli J; Williams EC; Longo WL; Kim KM; McGovern J; Jumonville A
    Cancer Invest; 2005; 23(1):13-8. PubMed ID: 15779863
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Paclitaxel-based treatment of lymphoma.
    Younes A
    Semin Oncol; 1999 Feb; 26(1 Suppl 2):123-8. PubMed ID: 10190794
    [TBL] [Abstract][Full Text] [Related]  

  • 10. No effect of 96-hour paclitaxel infusion in patients with relapsed non-Hodgkin's lymphoma refractory to a 3-hour infusion schedule.
    Younes A; Ayoub JP; Hagemeister FB; McLaughlin P; Sarris A; Rodriguez MA; Swan F; Romaguera JE; Martin J; Cabanillas F
    J Clin Oncol; 1996 Feb; 14(2):543-8. PubMed ID: 8636769
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phase I trial of fludarabine and paclitaxel in non-Hodgkin's lymphoma.
    Abbasi MR; Sparano JA; Sarta C; Wiernik PH
    Med Oncol; 2003; 20(1):53-8. PubMed ID: 12665685
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Comparison of the therapeutic effects of paclitaxel liposome-5-Fu versus paclitaxel-5-Fu on 67 patients with advanced gastric cancer].
    Wu F; Chen SC; Lu ZH; Xiong JP
    Zhonghua Zhong Liu Za Zhi; 2010 Mar; 32(3):234-6. PubMed ID: 20450596
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [New antitumor drugs for non-Hodgkin's lymphoma].
    Ohnishi K; Ohno R
    Gan To Kagaku Ryoho; 1998 Dec; 25(14):2223-8. PubMed ID: 9881079
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinical case of the month. The association of Hodgkin's disease and nephrotic syndrome].
    Baron F; Hermanne JP; Fassotte MF; Beguin Y; Fillet G
    Rev Med Liege; 1998 Nov; 53(11):651-3. PubMed ID: 9887654
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phase II trial of paclitaxel by 24-hour continuous infusion for relapsed non-Hodgkin's lymphomas: Southwest Oncology Group trial 9246.
    Press OW; LeBlanc M; O'Rourke TJ; Gagnet S; Chapman RA; Balcerzak SP; Fisher RI
    J Clin Oncol; 1998 Feb; 16(2):574-8. PubMed ID: 9469343
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mitoxantrone, vinblastine, and lomustine (CCNU) (MVC): a highly active regimen for advanced and poor-prognosis Hodgkin's disease.
    Wiernik PH; Dutcher JP; Einzig AI; Sparano J; Frank M; Friedenberg W
    Cancer J Sci Am; 1998; 4(4):254-60. PubMed ID: 9689984
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effects of etoposide on testicular function in boys treated for Hodgkin's disease.
    Gerres L; Brämswig JH; Schlegel W; Jürgens H; Schellong G
    Cancer; 1998 Nov; 83(10):2217-22. PubMed ID: 9827728
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nivolumab-induced cytokine-release syndrome in relapsed/refractory Hodgkin's lymphoma: a case report and literature review.
    Zhao L; Yang Y; Li W; Li T; Gao Q
    Immunotherapy; 2018 Aug; 10(11):913-917. PubMed ID: 30149764
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Granuloma annulare associated with Hodgkin's disease.
    Setoyama M; Kerdel FA; Byrnes JJ; Kanzaki T
    Int J Dermatol; 1997 Jun; 36(6):445-8. PubMed ID: 9248891
    [No Abstract]   [Full Text] [Related]  

  • 20. [The treatment of patients with refractory forms of Hodgkin's lymphomas].
    Hubareva HO; Kriachok IA; Tytorenko IB; Aleksyk OM; Novosad OI; Kadnikova TV; Martynchyk AV; Pastushenko IaV; Filonenko KS; Kushchevyĭ IeV
    Lik Sprava; 2010; (1-2):115-8. PubMed ID: 20608037
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.